PubMed HealthSearch

Biomedical subjects

C Haurie

Publications and source records attributed to C Haurie.

3 recordsLinked to original sources

Cyclical neutropenia and other periodic hematological disorders: a review of mechanisms and mathematical models.

Although all blood cells are derived from hematopoietic stem cells, the regulation of this production system is only partially understood. Negative feedback control mediated by erythropoietin and thrombopoietin regulates erythrocyte and platelet production, respectively, but the regulation of leukocyte levels is less well understood. The local regulatory mechanisms within the hematopoietic stem cells are also not well characterized at this point. Because of their dynamic character, cyclical neutropenia and other periodic hematological disorders offer a rare opportunity to more fully understand the nature of these regulatory processes. We review the salient clinical and laboratory features of cyclical neutropenia (and the less common disorders periodic chronic myelogenous leukemia, periodic auto-immune hemolytic anemia, polycythemia vera, aplastic anemia, and cyclical thrombocytopenia) and the insight into these diseases afforded by mathematical modeling. We argue that the available evidence indicates that the locus of the defect in most of these dynamic diseases is at the stem cell level (auto-immune hemolytic anemia and cyclical thrombocytopenia seem to be the exceptions). Abnormal responses to growth factors or accelerated cell loss through apoptosis may play an important role in the genesis of these disorders.

Anemia, Aplastic

Cyclical neutropenia and the peripheral control of white blood cell production.

Cyclical neutropenia (CN) is an interesting dynamic hematological disease in which the neutrophils spontaneously oscillate from approximately normal levels to near zero with a period between 19 and 21 days. In the only known animal model for this disorder, the grey collie, the disease's single apparent difference from human CN is the smaller period of 11-15 days. CN can be treated using the cytokine G-CSF which decreases the period (to about 14 days in humans), increases the mean value, and elevates the amplitude of the oscillations. After reviewing the clinical and laboratory data on this disease, we examine the proposition that CN is due to a loss of stability in the peripheral negative feedback control of neutrophil production. This is accomplished by the development of a physiologically realist mathematical model for the system. We conclude that there is no consistent way in which such a destabilization can give rise to either the clinical or laboratory characteristics of CN. Rather it seems more likely that the oscillations of CN are generated within the pluripotential stem cell population.

Feedback